PCMC
BIIB icon

Planning Capital Management Corporation’s Biogen BIIB Stock Holding History

Planning Capital Management Corporation’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11
Closed -$2.55K – 797
2024
Q2 		$2.55K Hold
11
– – ﹤0.01% 518
2024
Q1 		$2.37K Sell
11
-25
-69% -$5.86K ﹤0.01% 549
2023
Q4 		$9.32K Buy
+36
New +$8.84K 0.01% 422

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Planning Capital Management Corporation's BIIB Position: Q3 2024 in Review

Planning Capital Management Corporation sold out of Biogen (BIIB) in Q3 2024, closing a stake of 11 shares — an estimated $2.55K sold.

Planning Capital Management Corporation first reported a position in BIIB in Q4 2023 and held it in 3 quarters. The position peaked at $9.32K in Q4 2023. 917 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

  • Planning Capital Management Corporation reported no remaining Biogen position as of Q3 2024 after selling out during the quarter.
  • Planning Capital Management Corporation sold 11 Biogen shares in Q3 2024, an estimated $2.55K.
  • Planning Capital Management Corporation first reported a position in Biogen in Q4 2023 and held it in 3 quarters.
  • Planning Capital Management Corporation's Biogen position peaked at $9.32K in Q4 2023.
  • 917 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on Planning Capital Management Corporation's 13F filing for Q3 2024, filed 6 Nov 2024.